Clarius Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Clarius Group's BEAM Position: Q4 2025 in Review
Clarius Group held its Beam Therapeutics (BEAM) position steady in Q4 2025 at 60,615 shares worth $1.68M. The position accounts for 0.1% of the portfolio, ranked #84.
Clarius Group first reported a position in BEAM in Q2 2021 and has held it in 19 quarters since. The position peaked at $2M in Q1 2024. 248 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.
- Clarius Group held 60,615 shares of Beam Therapeutics worth $1.68M as of Q4 2025.
- Clarius Group left its Beam Therapeutics share count unchanged in Q4 2025.
- Beam Therapeutics made up 0.1% of Clarius Group's portfolio in Q4 2025, its #84 holding.
- Clarius Group first reported a position in Beam Therapeutics in Q2 2021 and has held it in 19 quarters since.
- Clarius Group's Beam Therapeutics position peaked at $2M in Q1 2024.
- 248 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.
Based on Clarius Group's 13F filing for Q4 2025, filed 14 Jan 2026.